8.11 Conclusions
I believe one-sided (benefit only) testing reflects a mindset of physicians and healthcare researchers who believe their intervention can produce no harm, a philosophy that has been shown repeatedly to be faulty, and dangerous to patients and their families. Investigators who agree to the one-sided (benefit only) approach to significance testing in a clinical experiment have closed parts of their minds to the possibility of harm entering into an avoidable flirtation with danger. In this sense, the one-sided test is not the disease, it is only a symptom.
We as physicians and healthcare workers feel strongly about the treatment programs we advocate. This is required in our profession. However, these strong feelings often betray us since our day-to-day experience does not provide an objective view of the treatments. We need every tool we can find to help us gain that objective vantage point. The use of a two-sided significance test is of utmost importance. A forceful, intelligent argument for ethics will argue not only for a two-sided test, but asymmetrical allocation of alpha. Prospective identification of alpha is again critical here, and community protection predominates all other concerns. A sensitive, perceptive, ethical approach to alpha allocation for sidedness can complicate experimental design, but complexity in the name of ethics is no vice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Knottnerus JA, Bouter LM (2001) Commentary: The ethics of sample size: two-sided testing and one-sided thinking. Journal of Clinical Epidemiology 54:109–110.
Leyman EL (1986) Testing Statistical Hypotheses. New York. John Wiley and Sons.
Moore T (1995) Deadly Medicine. New York Simon and Schuster.
The CAST Investigators (1989) Preliminary Report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New England Journal of Medicine. 3212:406–412.
The Lipid Research Clinic Investigators (1979) The Lipid Research Clinics Program: The Coronary Primary Prevention Trial; Design and implementation. Journal of Chronic Diseases 32:609–631.
The Lipid Research Clinic Investigators. (1984) The Lipid Research Clinics Coronary Primary Prevention trial results. Journal of the Amerian Medical Association 251: 351–74.
Moyé LA, Tita, A (2002) Defending the Rationale for the Two-Tailed Test in Clinical Research. Circulation 105: 3062–3065.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Moyé, L.A. (2006). One-Sided Versus Two-Sided Testing. In: Statistical Reasoning in Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-46212-7_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-46212-7_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-32913-0
Online ISBN: 978-0-387-46212-7
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)